Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Mol Genet Metab ; 133(1): 100-108, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33775523

RESUMEN

OBJECTIVE: Long-term outcomes of patients with mucopolysaccharidosis (MPS) VI treated with galsulfase enzyme replacement therapy (ERT) since infancy were evaluated. METHODS: The study was a multicenter, prospective evaluation using data from infants with MPS VI generated during a phase 4 study (ASB-008; Clinicaltrials.govNCT00299000) and clinical data collected ≥5 years after completion of the study. RESULTS: Parents of three subjects from ASB-008 (subjects 1, 2, and 4) provided written informed consent to participate in the follow-up study. One subject was excluded as consent was not provided. Subjects 1, 2, and 4 were aged 0.7, 0.3, and 1.1 years, respectively, at initiation of galsulfase and 10.5, 7.9, and 10.5 years, respectively, at follow-up. All subjects had classical MPS VI based on pre-treatment urinary glycosaminoglycans and the early onset of clinical manifestations. At follow-up, subject 4 had normal stature for age; subjects 1 and 2 had short stature, but height remained around the 90th percentile of growth curves for untreated classical MPS VI. Six-minute walk distance was normal for age/height in subjects 1 (550 m) and 4 (506 m), and reduced for subject 2 (340 m). Subject 2 preserved normal respiratory function, while percent predicted forced vital capacity and forced expiratory volume in 1 s decreased over time in the other subjects. Skeletal dysplasia was already apparent in all subjects at baseline and continued to progress. Cardiac valve disease showed mild progression in subject 1, mild improvement in subject 4, and remained trivial in subject 2. All subjects had considerably reduced pinch and grip strength at follow-up, but functional dexterity was relatively normal for age and there was limited impact on activities of daily living. Bruininks-Oseretsky Test of Motor Proficiency (BOT-2) results showed that subjects 2 and 4 had numerous fine and gross motor competencies. Corneal clouding progressed in all subjects, while progression of hearing impairment was variable. Liver size normalized from baseline in subjects 1 and 4, and remained normal in subject 2. CONCLUSION: Very early and continuous ERT appears to slow down the clinical course of MPS VI, as shown by preservation of endurance, functional dexterity, and several fine and gross motor competencies after 7.7-9.8 years of treatment, and less growth impairment or progression of cardiac disease than could be expected based on the patients' classical phenotype. ERT does not seem to prevent progression of skeletal or eye disease in the long term.


Asunto(s)
Condroitinsulfatasas/genética , Terapia de Reemplazo Enzimático , Mucopolisacaridosis VI/terapia , N-Acetilgalactosamina-4-Sulfatasa/genética , Actividades Cotidianas , Niño , Preescolar , Estudios de Seguimiento , Glicosaminoglicanos/orina , Humanos , Lactante , Masculino , Mucopolisacaridosis VI/genética , Mucopolisacaridosis VI/patología , Proteínas Recombinantes/genética , Pruebas de Función Respiratoria
2.
Pediatr Emerg Care ; 35(9): e172-e173, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28463946

RESUMEN

Congenital heart disease can be difficult to diagnose in infants because they often present with nonspecific symptoms. Their clinical presentation can resemble that of respiratory infections or sepsis, yet typical treatments for these conditions such as fluid resuscitation may worsen their course. We report a case of an 8-week-old boy who had several weeks of viral symptoms and eventually presented to the emergency department in shock. An echocardiogram revealed the diagnosis of cor triatriatum, a rare congenital heart disease that requires urgent surgical repair. In this article, we review the evaluation and management of such patients and emphasize the importance of considering congenital heart disease in the differential diagnosis for an infant in shock.


Asunto(s)
Corazón Triatrial/diagnóstico , Choque/etiología , Corazón Triatrial/complicaciones , Diagnóstico Diferencial , Ecocardiografía , Insuficiencia de Crecimiento/etiología , Humanos , Lactante , Masculino
3.
Ann Hematol ; 93(7): 1139-48, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24577514

RESUMEN

A high tricuspid regurgitant jet velocity (TRV) signifies a risk for or established pulmonary hypertension (PH), which is a serious complication in thalassemia patients. The underlying pathophysiology in thalassemia subgroups and potential biomarkers for early detection and monitoring are not well defined, in particular as they relate to spleen removal. To better understand some of these unresolved aspects, we examined 76 thalassemia patients (35 non-transfused), 25 splenectomized non-thalassemia patients (15 with hereditary spherocytosis), and 12 healthy controls. An elevated TRV (>2.5 m/s) was found in 25/76 (33 %) of the patients, confined to non-transfused or those with a late start of transfusions, including patients with hemoglobin H-constant spring, a finding not previously described. These non or late-transfused patients (76 % splenectomized) had significantly increased platelet activation (sCD40L), high platelet count, endothelial activation (endothelin-1), and hemolysis (LDH, plasma-free Hb), while hypercoagulable and inflammatory markers were not significantly increased. The same markers were increased in the seven patients with confirmed PH on cardiac catheterization, suggesting their possible role for screening patients at risk for PH. A combination of hemolysis and absence of spleen is necessary for developing a high TRV, as neither chronic hemolysis in the non-splenectomized thalassemia patients nor splenectomy without hemolysis, in the non-thalassemia patients, resulted in an increase in TRV.


Asunto(s)
Esplenectomía , Talasemia/fisiopatología , Talasemia/cirugía , Insuficiencia de la Válvula Tricúspide/fisiopatología , Insuficiencia de la Válvula Tricúspide/cirugía , Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esplenectomía/métodos , Talasemia/sangre , Resultado del Tratamiento , Insuficiencia de la Válvula Tricúspide/sangre , Adulto Joven
4.
J Inherit Metab Dis ; 34(6): 1183-97, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21744090

RESUMEN

The mucopolysaccharidoses (MPSs) are inherited lysosomal storage disorders caused by the absence of functional enzymes that contribute to the degradation of glycosaminoglycans (GAGs). The progressive systemic deposition of GAGs results in multi-organ system dysfunction that varies with the particular GAG deposited and the specific enzyme mutation(s) present. Cardiac involvement has been reported in all MPS syndromes and is a common and early feature, particularly for those with MPS I, II, and VI. Cardiac valve thickening, dysfunction (more severe for left-sided than for right-sided valves), and hypertrophy are commonly present; conduction abnormalities, coronary artery and other vascular involvement may also occur. Cardiac disease emerges silently and contributes significantly to early mortality.The clinical examination of individuals with MPS is often difficult due to physical and, sometimes, intellectual patient limitations. The absence of precordial murmurs does not exclude the presence of cardiac disease. Echocardiography and electrocardiography are key diagnostic techniques for evaluation of valves, ventricular dimensions and function, which are recommended on a regular basis. The optimal technique for evaluation of coronary artery involvement remains unsettled.Standard medical and surgical techniques can be modified for MPS patients, and systemic therapies such as hematopoietic stem cell transplantation and enzyme replacement therapy (ERT) may alter overall disease progression with regression of ventricular hypertrophy and maintenance of ventricular function. Cardiac valve disease is usually unresponsive or, at best, stabilized, although ERT within the first few months of life may prevent valve involvement, a fact that emphasizes the importance of early diagnosis and treatment in MPS.


Asunto(s)
Glicosaminoglicanos/metabolismo , Enfermedades de las Válvulas Cardíacas/diagnóstico , Enfermedades de las Válvulas Cardíacas/epidemiología , Hipertrofia Ventricular Izquierda/diagnóstico , Hipertrofia Ventricular Izquierda/epidemiología , Mucopolisacaridosis/epidemiología , Adolescente , Adulto , Edad de Inicio , Estenosis de la Válvula Aórtica/diagnóstico , Estenosis de la Válvula Aórtica/epidemiología , Causalidad , Niño , Preescolar , Comorbilidad , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/epidemiología , Ecocardiografía , Electrocardiografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia de la Válvula Mitral/diagnóstico , Insuficiencia de la Válvula Mitral/epidemiología , Mucopolisacaridosis/clasificación , Mucopolisacaridosis/terapia , Taquicardia Sinusal/diagnóstico , Taquicardia Sinusal/epidemiología
5.
Ann Thorac Surg ; 91(2): e23-5, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21256259

RESUMEN

Aortico-left ventricle tunnels are rare congenital anomalies with variable anatomy; however, by definition, they consist of an abnormal connection between the ascending aorta and the left ventricle. Diagnosis is usually by echocardiography, and treatment typically uses a two-patch surgical repair. Herein, we describe a case of an aortico-left ventricle tunnel, with the tunnel bifurcating before entering the left ventricle. Preoperative echocardiography and magnetic resonance imaging show the lesion in great detail. Two patches were required on the left-ventricular side of the tunnel for closure. A bifurcating aortico-left ventricle tunnel has not yet been described in the literature. The preoperative imaging and surgical management are discussed.


Asunto(s)
Aorta/anomalías , Aorta/cirugía , Cardiopatías Congénitas/diagnóstico , Cardiopatías Congénitas/cirugía , Ventrículos Cardíacos/anomalías , Ventrículos Cardíacos/cirugía , Procedimientos Quirúrgicos Cardíacos , Preescolar , Ecocardiografía Transesofágica , Humanos , Angiografía por Resonancia Magnética , Imagen por Resonancia Magnética , Masculino
6.
Am J Hematol ; 81(9): 670-5, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16795058

RESUMEN

The pathogenesis of pulmonary hypertension (PAH), a serious complication in thalassemia, is not well understood. Thromboembolism has been postulated as one of the causative factors; however, there are currently limited specific data on its role. To examine whether increased platelet activation and hypercoagulability are linked to PAH, 25 beta-thalassemia major and beta-thalassemia intermedia patients were evaluated with Doppler echocardiograms for estimation of pulmonary artery pressure and with laboratory assays for indications of a prothrombotic state. The association of clinical variables and abnormal coagulation assays with PAH was determined. PAH was identified in 17 (68%) patients; mean pulmonary artery systolic pressure was 39.8 +/- 5.4 mm Hg. PAH was significantly associated with prior splenectomy, older age, and evidence for chronic hemolysis, diagnosed in both transfused (n = 10) and nontransfused (n = 7) patients. Increased platelet activation, measured by P-selectin, was significantly associated with PAH (P = 0.001). Increased thrombin-antithrombin III level was more prevalent in the presence of PAH, but increased fibrinolysis or low protein C levels were not. This study underscores the role of platelet activation in the development of PAH and stresses its occurrence even among patients who are regularly transfused, especially those who are older and have had splenectomies.


Asunto(s)
Envejecimiento/sangre , Hipertensión Pulmonar/etiología , Activación Plaquetaria , Trombofilia/complicaciones , Talasemia beta/complicaciones , Adolescente , Adulto , Niño , Humanos , Hipertensión Pulmonar/sangre , Persona de Mediana Edad , Selectina-P/sangre , Recuento de Plaquetas , Esplenectomía , Trombofilia/sangre , Talasemia beta/sangre , Talasemia beta/cirugía
7.
J Soc Psychol ; 106(2): 215-225, 1978 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28135540

RESUMEN

Hall's pioneering studies designated discrete zones of interpersonal space appropriate to levels of intimacy within a culture. This project investigated variables expected to affect reactions of Ss to entry into their intimate zone by strangers. Violations of Hall's intimate zone were predicted to be more aversive to males when accompanied by physical contact and when lacking prior psychological justification. In Experiment 1 a female confederate (C) sat six inches from individual Ss (21 males and 23 females) and touched half the Ss. Half the Ss were given a rationalization for the C's intrusion. Experiment 2 was a replication with a male C and 40 male and 40 female Ss. Aversive reactions were measured by decrements in performance and liking. As predicted, touch and no justification resulted in significantly lower task performance by males only, regardless of sex of intruder. Intrusions decreased liking by males and increased liking by females. It is concluded that proxemic theory should be elaborated to account for the effects of touch, justification, and sex.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA